Physician profile
Malcolm L Howell
NPI 1356321210
$1,793.29
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $531 · 2020: $557 · 2021: $301 · 2022: $279 · 2023: $126.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $126.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $125.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $632.29 | 2019-2023 | |
| Minerva Surgical, INC | $349.17 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $216.99 | 2019-2023 | |
| Exeltis, USA INC. | $114.62 | 2019-2023 | Slynd |
| Mayne Pharma Commercial LLC | $95.83 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $75.22 | 2019-2021 | |
| Organon LLC | $52.00 | 2021-2023 | Nexplanon |
| Therapeuticsmd, INC. | $51.32 | 2019-2021 | |
| Mylan Pharmaceuticals INC. | $36.75 | 2019-2021 | |
| Allergan, INC. | $22.95 | 2019 | |
| Boston Scientific Corporation | $19.06 | 2023 | Upsylon |
| Duchesnay USA Incorporated | $17.63 | 2019 | |
| Novo Nordisk INC | $16.35 | 2022 | |
| Renovia INC | $15.85 | 2021 | |
| Hologic Sales and Service, LLC | $14.69 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $13.80 | 2021 | |
| Pfizer INC. | $12.81 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $12.55 | 2019 | |
| Coopersurgical, INC. | $12.24 | 2020 | |
| Vertical Pharmaceuticals, LLC | $11.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Malcolm Howell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.